Director Michelle Seitz gets 90,000 Sana (SANA) stock options
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Sana Biotechnology director Michelle Seitz received a grant of stock options for 90,000 shares of common stock. The options have an exercise price of $2.96 per share and expire on June 3, 2036. They vest and become fully exercisable on the earlier of June 4, 2027 or immediately prior to Sana’s 2027 annual stockholder meeting, as long as she continues to provide service to the company through that date. Following this award, she holds 90,000 stock options directly, reflecting a compensation-related acquisition rather than an open-market share purchase.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Seitz Michelle
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 90,000 | $0.00 | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 90,000 shares (Direct, null)
Footnotes (1)
- [object Object]
Key Figures
Option grant size: 90,000 options
Exercise price: $2.96 per share
Expiration date: June 3, 2036
+3 more
6 metrics
Option grant size
90,000 options
Stock Option (Right to Buy) grant to director
Exercise price
$2.96 per share
Conversion or exercise price of options
Expiration date
June 3, 2036
Option expiration date
Vesting date trigger
June 4, 2027
Earlier of this date or 2027 annual meeting
Underlying shares
90,000 shares
Common stock underlying the options
Post-grant derivative holdings
90,000 options
Total options held following transaction
Key Terms
Stock Option (Right to Buy), exercise price, vesting, expiration date, +1 more
5 terms
Stock Option (Right to Buy) financial
"security_title: Stock Option (Right to Buy)"
exercise price financial
"conversion_or_exercise_price: 2.9600 per share"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"The option vests and becomes exercisable as to 100% of the underlying shares"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
expiration date financial
"expiration_date: 2036-06-03T00:00:00.000Z"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
underlying security financial
"underlying_security_title: Common Stock"
FAQ
What did Sana Biotechnology director Michelle Seitz receive in this Form 4 filing for SANA?
Michelle Seitz received a grant of stock options for 90,000 shares of Sana common stock. The options are a compensation-related award, not an open-market purchase, and give her the right to buy shares at a fixed exercise price.
What is the exercise price of Michelle Seitz’s new Sana (SANA) stock options?
The stock options have an exercise price of $2.96 per share. This means Seitz can buy Sana common stock at $2.96 once the options vest and she chooses to exercise them before the options expire.
When do Michelle Seitz’s Sana Biotechnology (SANA) options vest?
The options vest 100% on the earlier of June 4, 2027 or immediately before Sana’s 2027 annual stockholder meeting. Vesting requires that Seitz continue to provide service to the company through the applicable vesting date.
When do the stock options granted to Michelle Seitz at Sana (SANA) expire?
The stock options expire on June 3, 2036. If Seitz does not exercise the options by that expiration date, they will lapse and she will no longer have the right to buy Sana common stock at the exercise price.
How many Sana Biotechnology (SANA) options does Michelle Seitz hold after this grant?
After this grant, Seitz holds 90,000 stock options directly. These options each relate to one share of Sana common stock and represent her reported derivative holdings following the compensation award described in the Form 4.